Diabetes Care Devices
Feb 18, 2026
Diabetes Care Devices: Transforming Management Through Innovation and Precision
Diabetes care devices are becoming increasingly vital as the global burden of diabetes continues to rise. Today, more than 530 million adults worldwide live with diabetes, a number projected to increase in the future. The condition requires continuous monitoring and timely intervention to prevent serious complicati...
Read More...
Jan 15, 2026
Medtronic Diabetes Secures FDA Clearance for MiniMed Go™ Smart MDI Platform; Neurolief Achieves FDA PMA Approval for Novel At-Home Brain Stimulation Therapy for Depression; Haemonetics Completes Acquisition of Vivasure Medical Limited; Boston Scientific Enters Agreement to Acquire Valencia Technologies; Butterfly Medical Completes Pivotal Trial for Minimally Invasive BPH Therapy; TYBR Health Announces First U.S. Clinical Use of the B3 GEL™ System
Medtronic Diabetes Announced FDA Clearance for MiniMed Go™ Smart MDI System Featuring Instinct Sensor Made by Abbott On January 12, 2026, Medtronic, a global leader in healthcare technology, announced that it had received U.S. Food and Drug Administration (FDA) 510(k) clearance for its MiniMed Go™ app. The MiniM...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
